SG11201602826VA - Icotinib-containing topical skin pharmaceutical compositions and uses thereof - Google Patents

Icotinib-containing topical skin pharmaceutical compositions and uses thereof

Info

Publication number
SG11201602826VA
SG11201602826VA SG11201602826VA SG11201602826VA SG11201602826VA SG 11201602826V A SG11201602826V A SG 11201602826VA SG 11201602826V A SG11201602826V A SG 11201602826VA SG 11201602826V A SG11201602826V A SG 11201602826VA SG 11201602826V A SG11201602826V A SG 11201602826VA
Authority
SG
Singapore
Prior art keywords
icotinib
pharmaceutical compositions
topical skin
containing topical
skin pharmaceutical
Prior art date
Application number
SG11201602826VA
Inventor
Yinxiang Wang
Shujun Yuan
Yanping Wang
Shaojing Hu
Yunyan Hu
Original Assignee
Betta Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betta Pharmaceuticals Co Ltd filed Critical Betta Pharmaceuticals Co Ltd
Publication of SG11201602826VA publication Critical patent/SG11201602826VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201602826VA 2013-10-11 2014-10-11 Icotinib-containing topical skin pharmaceutical compositions and uses thereof SG11201602826VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2013085042 2013-10-11
PCT/CN2014/088344 WO2015051763A1 (en) 2013-10-11 2014-10-11 Icotinib-containing topical skin pharmaceutical composition and use thereof

Publications (1)

Publication Number Publication Date
SG11201602826VA true SG11201602826VA (en) 2016-05-30

Family

ID=52812537

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602826VA SG11201602826VA (en) 2013-10-11 2014-10-11 Icotinib-containing topical skin pharmaceutical compositions and uses thereof

Country Status (13)

Country Link
US (2) US20160235757A1 (en)
EP (1) EP3056206A4 (en)
JP (1) JP6463745B2 (en)
AU (1) AU2014334222B2 (en)
BR (1) BR112016007627A2 (en)
CA (1) CA2926874C (en)
HK (1) HK1213813A1 (en)
IL (1) IL245015A0 (en)
NZ (1) NZ718802A (en)
RU (1) RU2698796C2 (en)
SG (1) SG11201602826VA (en)
TW (1) TWI630921B (en)
WO (1) WO2015051763A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2638646T3 (en) * 2013-06-09 2017-10-23 Betta Pharmaceuticals Co., Ltd. New polymorphic forms of Icotinib phosphate and uses thereof
WO2022022434A1 (en) * 2020-07-27 2022-02-03 杭州和正医药有限公司 Pharmaceutical composition and preparation containing pharmaceutically acceptable salt of tofacitinib and use thereof
CN116829152A (en) * 2021-02-02 2023-09-29 贝达药业股份有限公司 Application of Icotinib in postoperative adjuvant therapy of non-small cell lung cancer
WO2023143345A1 (en) * 2022-01-25 2023-08-03 杭州和正医药有限公司 Tofacitinib-containing pharmaceutical composition for topical application, preparation, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007060116A2 (en) * 2005-11-24 2007-05-31 Basf Se Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules that support carboxylic groups or sulfonic acid groups
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
US8822482B2 (en) * 2008-07-08 2014-09-02 Beta Pharma, Inc. Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof
GB201010954D0 (en) * 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
MX2013004296A (en) * 2010-10-21 2013-09-26 Cadila Healthcare Ltd Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis.

Also Published As

Publication number Publication date
AU2014334222B2 (en) 2017-03-09
RU2016118063A (en) 2017-11-16
CA2926874C (en) 2018-12-11
WO2015051763A1 (en) 2015-04-16
AU2014334222A1 (en) 2016-05-05
JP6463745B2 (en) 2019-02-06
US20190321369A1 (en) 2019-10-24
US20160235757A1 (en) 2016-08-18
TWI630921B (en) 2018-08-01
HK1213813A1 (en) 2016-07-15
NZ718802A (en) 2017-09-29
EP3056206A4 (en) 2017-07-05
IL245015A0 (en) 2016-05-31
EP3056206A1 (en) 2016-08-17
RU2698796C2 (en) 2019-08-30
TW201513894A (en) 2015-04-16
CA2926874A1 (en) 2015-04-16
JP2016532659A (en) 2016-10-20
BR112016007627A2 (en) 2017-08-01

Similar Documents

Publication Publication Date Title
HK1226301A1 (en) Modified therapeutic agents and compositions thereof
HRP20180635T1 (en) Pyrazole-amide compound and medicinal uses therefor
ZA201602510B (en) Strigolactone formulations and uses thereof
EP2961382A4 (en) Topical compositions and methods of using the same
EP2968474A4 (en) Skin compositions and uses
HK1220920A1 (en) Therapeutic compositions and uses thereof
HK1222563A1 (en) Pharmaceutical composition, preparation and uses thereof
EP2968107A4 (en) Cosmetic compositions and uses thereof
EP3007720A4 (en) Compositions comprising gc- macrophage activating factor and uses thereof
HK1219691A1 (en) Pharmaceutical composition and uses thereof
GB201320932D0 (en) Topical pharmaceutical composition
HK1213813A1 (en) Icotinib-containing topical skin pharmaceutical compositions and uses thereof
ZA201504604B (en) Skin care composition
IL240177A0 (en) Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
EP3055286A4 (en) 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
GB201316498D0 (en) Topical Pharmaceutical formulation
AU2013901834A0 (en) Formulations and Therapeutic Uses Thereof
HK1186053A2 (en) Skin care composition